Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinocerebellar Ataxias | 7 | 2019 | 98 | 2.030 |
Why?
|
| Calcium Channels | 6 | 2019 | 180 | 2.000 |
Why?
|
| Cerebellum | 4 | 2022 | 253 | 1.300 |
Why?
|
| Transcription Factors | 5 | 2022 | 1717 | 0.920 |
Why?
|
| Calcium Channels, N-Type | 5 | 2019 | 40 | 0.870 |
Why?
|
| Purkinje Cells | 4 | 2018 | 87 | 0.650 |
Why?
|
| Chlorzoxazone | 1 | 2020 | 6 | 0.630 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2020 | 11 | 0.630 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2020 | 19 | 0.620 |
Why?
|
| MicroRNAs | 3 | 2022 | 604 | 0.620 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 26 | 0.530 |
Why?
|
| Internal Ribosome Entry Sites | 4 | 2019 | 16 | 0.530 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2018 | 61 | 0.530 |
Why?
|
| Exons | 1 | 2018 | 451 | 0.470 |
Why?
|
| Mitochondria | 1 | 2020 | 650 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 668 | 0.430 |
Why?
|
| Rats | 5 | 2022 | 4071 | 0.420 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2009 | 11 | 0.300 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 118 | 0.280 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 1604 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 215 | 0.270 |
Why?
|
| Testosterone | 1 | 2009 | 265 | 0.260 |
Why?
|
| Animals | 10 | 2022 | 28894 | 0.240 |
Why?
|
| Adipose Tissue | 1 | 2009 | 280 | 0.240 |
Why?
|
| Mice | 5 | 2022 | 12698 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 750 | 0.210 |
Why?
|
| HEK293 Cells | 4 | 2019 | 721 | 0.200 |
Why?
|
| Transfection | 3 | 2020 | 883 | 0.190 |
Why?
|
| Neurogenesis | 1 | 2022 | 93 | 0.170 |
Why?
|
| Dependovirus | 1 | 2020 | 38 | 0.160 |
Why?
|
| Xenopus | 1 | 2020 | 120 | 0.150 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 53 | 0.150 |
Why?
|
| Oocytes | 1 | 2020 | 213 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 256 | 0.150 |
Why?
|
| RNA, Messenger | 2 | 2022 | 2063 | 0.150 |
Why?
|
| Transcription Initiation Site | 1 | 2019 | 49 | 0.140 |
Why?
|
| PC12 Cells | 1 | 2019 | 112 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2020 | 524 | 0.140 |
Why?
|
| Genetic Vectors | 1 | 2020 | 426 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 548 | 0.140 |
Why?
|
| Calcium Channels, L-Type | 1 | 2018 | 38 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 993 | 0.130 |
Why?
|
| HeLa Cells | 1 | 2019 | 523 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2572 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2023 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2019 | 373 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 1565 | 0.120 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2015 | 3 | 0.120 |
Why?
|
| Lactoylglutathione Lyase | 1 | 2015 | 6 | 0.120 |
Why?
|
| Pyruvaldehyde | 1 | 2015 | 10 | 0.120 |
Why?
|
| Anti-Anxiety Agents | 1 | 2015 | 23 | 0.120 |
Why?
|
| Cell Line | 1 | 2020 | 2483 | 0.110 |
Why?
|
| Humans | 12 | 2022 | 98080 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 160 | 0.110 |
Why?
|
| Neurites | 1 | 2013 | 38 | 0.100 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2012 | 7 | 0.090 |
Why?
|
| Cell Death | 1 | 2013 | 257 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2012 | 209 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 977 | 0.080 |
Why?
|
| Peptides | 1 | 2013 | 669 | 0.080 |
Why?
|
| Aldo-Keto Reductase Family 1 Member C3 | 1 | 2009 | 3 | 0.070 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2009 | 6 | 0.070 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2009 | 16 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2009 | 157 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 2896 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1133 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 293 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2007 | 15 | 0.070 |
Why?
|
| Alu Elements | 1 | 2007 | 16 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 221 | 0.070 |
Why?
|
| Chromosome Disorders | 1 | 2007 | 97 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1619 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2888 | 0.060 |
Why?
|
| Gene Rearrangement | 1 | 2007 | 175 | 0.060 |
Why?
|
| Adolescent | 1 | 2020 | 10080 | 0.060 |
Why?
|
| Neoplasms | 1 | 2022 | 3334 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1138 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 2222 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 512 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2855 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1225 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2016 | 780 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1950 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 66 | 0.050 |
Why?
|
| Female | 3 | 2020 | 51536 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 480 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 3598 | 0.030 |
Why?
|
| Ajmaline | 1 | 2018 | 2 | 0.030 |
Why?
|
| Voltage-Gated Sodium Channel Blockers | 1 | 2018 | 3 | 0.030 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2018 | 4 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2018 | 61 | 0.030 |
Why?
|
| Mutation | 3 | 2018 | 4392 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 139 | 0.030 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2015 | 4 | 0.030 |
Why?
|
| Synapsins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 31 | 0.030 |
Why?
|
| Microinjections | 1 | 2015 | 67 | 0.030 |
Why?
|
| Midazolam | 1 | 2015 | 48 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2015 | 37 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 310 | 0.030 |
Why?
|
| Genes | 1 | 2016 | 256 | 0.030 |
Why?
|
| Genotype | 2 | 2012 | 1888 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 301 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 564 | 0.030 |
Why?
|
| Clinical Coding | 1 | 2012 | 23 | 0.020 |
Why?
|
| Yeasts | 1 | 2012 | 50 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1815 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 275 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 334 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 263 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 271 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 923 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 310 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2005 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1391 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2007 | 64 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 438 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 2638 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 980 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2555 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 4001 | 0.010 |
Why?
|
| Male | 2 | 2015 | 47076 | 0.010 |
Why?
|